Focus on blockbusters slows progress in the war on cancer

04/24/2014 | Daily Beast, The

As big drugmakers focus on finding the next blockbuster cancer drug, research on promising, inexpensive treatments, such as aspirin for breast cancer, often goes unfunded. "If we are winning the war on cancer, we are not winning that fast," said Dr. Vikas Sukhatme, the Victor J. Aresty Professor of Medicine at Harvard Medical School. Sukhatme and his wife, Vidula, an epidemiologist, founded the nonprofit GlobalCures to promote what they call financial orphans: less-expensive but still promising treatments that do not attract drugmakers' interest.

View Full Article in:

Daily Beast, The

Published in Brief: